• M&As : GlaxoSmithKline, Takeda, Procter & Gamble pharmaceutical-technology
    December 10, 2018
    GlaxoSmithKline (GSK) has agreed to acquire US-based cancer treatment developer Tesaro for $5.1bn.GSK will acquire all issued and outstanding.....
PharmaSources Customer Service